QPS Holdings LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:QPS Holdings LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10839
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥100,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
QPS Holdings LLC (QPS) is a contract research organization that offers bioanalytical contract services. The organization’s services include neuropharmacology, toxicology, DMPK, bioanalysis, translational medicine, clinical development, clinical research, and dermal and transdermal research services. Its clinical development services comprise site management and monitoring, patient recruitment, project and program management, vaccine studies, microdosing studies, drug interaction studies, study design and protocol writing, imaging studies and bioequivalence studies. QPS provides bioanalysis technology platforms including LC-MS/MS, LC-radio flow detection, ligand binding assay, and vaccines and hybridization-LBA. The organization caters its services to pharmaceutical and biotechnology companies. It operates bioanalytical facilities in the US, Austria, the Netherlands, India and Taiwan. QPS is headquartered in Newark, Delaware, the US.

QPS Holdings LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
QPS Holdings LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
QPS Holdings LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
QPS Holdings LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
QPS Holdings LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
QPS Holdings LLC, Medical Devices Deals, 2012 to YTD 2018 9
QPS Holdings LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
QPS Holdings LLC, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Amorfix Life Sciences Enters Into Licensing Agreement With JSW-Lifesciences 11
QPS Enters into Agreement with G-CURE 12
AB Sciex Enters into Agreement with QPS Holdings 13
QPS Holdings Forms Joint Venture with Intellim Corporation 14
Licensing Agreements 15
QPS Austria Enters into Licensing Agreement with Probiodrug 15
QPS Enters Into Licensing Agreement With Hepregen For HepatoPac And HepatoMune Products 16
Acquisition 17
QPS Holdings Acquires Miami Research 17
QPS Acquires Majority Stake In JSW Lifesciences 19
QPS Holdings LLC – Key Competitors 20
QPS Holdings LLC – Key Employees 21
QPS Holdings LLC – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Joint Venture 23
Recent Developments 24
Strategy And Business Planning 24
Jun 27, 2017: QPS Delaware Greatly Expands Translational Medicine Capabilities 24
Other Significant Developments 25
Mar 23, 2017: QPS Finalizes a Five Year Senior Credit Facility with Three Leading US Financial Institutions 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
QPS Holdings LLC, Pharmaceuticals & Healthcare, Key Facts 2
QPS Holdings LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
QPS Holdings LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
QPS Holdings LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
QPS Holdings LLC, Deals By Therapy Area, 2012 to YTD 2018 8
QPS Holdings LLC, Medical Devices Deals, 2012 to YTD 2018 9
QPS Holdings LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Amorfix Life Sciences Enters Into Licensing Agreement With JSW-Lifesciences 11
QPS Enters into Agreement with G-CURE 12
AB Sciex Enters into Agreement with QPS Holdings 13
QPS Holdings Forms Joint Venture with Intellim Corporation 14
QPS Austria Enters into Licensing Agreement with Probiodrug 15
QPS Enters Into Licensing Agreement With Hepregen For HepatoPac And HepatoMune Products 16
QPS Holdings Acquires Miami Research 17
QPS Acquires Majority Stake In JSW Lifesciences 19
QPS Holdings LLC, Key Competitors 20
QPS Holdings LLC, Key Employees 21
QPS Holdings LLC, Other Locations 22
QPS Holdings LLC, Subsidiaries 22
QPS Holdings LLC, Joint Venture 23

List of Figures
QPS Holdings LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
QPS Holdings LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
QPS Holdings LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
QPS Holdings LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
QPS Holdings LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
QPS Holdings LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
QPS Holdings LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
QPS Holdings LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
QPS Holdings LLC, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[QPS Holdings LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • City of Hope-製薬・医療分野:企業M&A・提携分析
    Summary City of Hope (COH) is a biomedical research organization that offers cancers, diabetes and infectious diseases treatment services. The organization offers services in the fields of anesthesiology, interventional radiology, surgery, donor matching and marrow transplants, rehabilitation servic …
  • Western Digital Corp (WDC):企業の財務・戦略的SWOT分析
    Western Digital Corp (WDC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Novaliq GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Novaliq GmbH (Novaliq) is a drug delivery company that develops pharmaceutical formulations. The company develops dermatological products, novel ophthalmic, and solutions for organ preservation based on the physicochemical properties of semifluorinated alkanes. It offers NovaTears a preserva …
  • Sunshine Biopharma Inc (SBFM):製薬・医療:M&Aディール及び事業提携情報
    Summary Sunshine BioPharma Inc (Sunshine BioPharma), a subsidiary of Advanomics Corp is a pharmaceutical company that offers research, development and commercialization of drugs for treating cancer disease. The company provides generic and proprietary drugs for the treatment of cancer and other acut …
  • SerComm Corp (5388):企業の財務・戦略的SWOT分析
    SerComm Corp (5388) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Science Applications International Corp:企業の戦略・SWOT・財務分析
    Science Applications International Corp - Strategy, SWOT and Corporate Finance Report Summary Science Applications International Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • OGK-2 (OGKB):企業の財務・戦略的SWOT分析
    OGK-2 (OGKB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • SEEK Limited:企業の戦略・SWOT・財務情報
    SEEK Limited - Strategy, SWOT and Corporate Finance Report Summary SEEK Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • The National Commercial Bank:企業の戦略・SWOT・財務情報
    The National Commercial Bank - Strategy, SWOT and Corporate Finance Report Summary The National Commercial Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • GI Dynamics Inc (GID):医療機器:M&Aディール及び事業提携情報
    Summary GI Dynamics Inc (GI Dynamics) is a clinical stage medical device company that develops and commercializes endoscopy instruments. The company develops EndoBarrier, a device to treat type 2 diabetes and obesity, which is delivered endoscopically. The device imitates the mechanisms of metabolic …
  • Nuo Therapeutics Inc (AURX):製薬・医療:M&Aディール及び事業提携情報
    Summary Nuo Therapeutics Inc (Nuo Therapeutics), formerly Cytomedix, is a biomedical company that specializes in biodynamic therapies in the area of wound care. It focuses on commercializing cell-based technologies, which bind the regenerative capacity of the human body to trigger natural healing. T …
  • United Community Banks Inc:企業のM&A・事業提携・投資動向
    United Community Banks Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's United Community Banks Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Kamada Ltd (KMDA):企業の財務・戦略的SWOT分析
    Kamada Ltd (KMDA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Cisco Systems, Inc.:企業の戦略・SWOT・財務情報
    Cisco Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary Cisco Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • L3 Technologies Inc (LLL):企業の戦略的SWOT分析
    L3 Technologies Inc (LLL) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Impinj Inc (PI):企業の財務・戦略的SWOT分析
    Impinj Inc (PI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Saline Water Conversion Corp:企業の戦略的SWOT分析
    Saline Water Conversion Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Hospira Inc:医療機器:M&Aディール及び事業提携情報
    Summary Hospira Inc (Hospira), a subsidiary of Pfizer Inc, is a medical device company that offers injectable drugs and infusion technologies. The company offers products such as generic acute-care and oncology injectables, biosimilars, infusion systems, IV sets, IV safety devices, biosimilars, diff …
  • P.F. Chang’s China Bistro, Inc.:企業の戦略・SWOT・財務情報
    P.F. Chang's China Bistro, Inc. - Strategy, SWOT and Corporate Finance Report Summary P.F. Chang's China Bistro, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • GMR Infrastructure Ltd (GMRINFRA):企業の財務・戦略的SWOT分析
    GMR Infrastructure Ltd (GMRINFRA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆